Today the U.S. Food and Drug Administration approved the Senza spinal cord stimulation (SCS) system (Senza System) as an aid in the management of chronic intractable pain of the trunk and/or limbs, including pain associated with failed back surgery syndrome, low back pain and leg pain. The Senza System can reduce pain without producing a tingling sensation called paresthesia by providing high frequency stimulation (at 10 KHz) and low stimulation amplitudes.
All posts by admin
FDA approves spinal cord stimulation system that treats pain without tingling sensation
Today the U.S. Food and Drug Administration approved the Senza spinal cord stimulation (SCS) system (Senza System) as an aid in the management of chronic intractable pain of the trunk and/or limbs, including pain associated with failed back surgery syndrome, low back pain and leg pain. The Senza System can reduce pain without producing a tingling sensation called paresthesia by providing high frequency stimulation (at 10 KHz) and low stimulation amplitudes.
FDA approves additional antibacterial treatment for plague
The U.S. Food and Drug Administration today approved Avelox (moxifloxacin) to treat patients with plague, a rare and potentially fatal bacterial infection. The agency approval for plague includes use of the drug for the treatment of pneumonic plague (infection of the lungs), and septicemic plague (infection of the blood). Avelox is also approved for prevention of plague in adult patients.
FDA approves additional antibacterial treatment for plague
The U.S. Food and Drug Administration today approved Avelox (moxifloxacin) to treat patients with plague, a rare and potentially fatal bacterial infection. The agency approval for plague includes use of the drug for the treatment of pneumonic plague (infection of the lungs), and septicemic plague (infection of the blood). Avelox is also approved for prevention of plague in adult patients.
Golden Krust Caribbean Bakery & Grill Issues Allergy Alert on Undeclared Egg in Jamaican Style Shrimp and Soya Patties
Golden Krust Caribbean Bakery & Grill of Bronx, NY is recalling 6,188 cases of Shrimp and Soya Patties, Net Wt. 17.2 lbs, due to an undeclared egg allergen. People who have an allergy or severe sensitivity to eggs run the risk of serious or life-threatening allergic reaction if they consume these products.
Teva Parenteral Medicines Initiates Voluntary Nationwide Recall of Select Lots of Adrucil® (fluorouracil Injection, Usp) 5 G/100 Ml (50 Mg/ml) Due to Particulate Matter
Teva Parenteral Medicines today announced a voluntary recall of eight lots of Adrucil® (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) due to the potential presence of particulate matter identified as aggregate of silicone rubber pieces from a filler diaphragm and fluorouracil crystals.
Poco Dolce Confections Announces Recall of Individually Wrapped Tile Varieties: Almond, Aztec Chile, Burnt Caramel, Almond Coconut, Ginger, and Sesame Toffee
Poco Dolce Confections of San Francisco, CA is recalling all Almond, Aztec Chile, Burnt Caramel, Almond Coconut, Ginger, and Sesame Toffee Individually Wrapped Tiles. These varieties of individually wrapped Tiles are being recalled because of their label’s failure to identify the food allergen (Milk) in addition to the listing for “Butter” in the label’s ingredient statement.
Read The Complete Story!
Kent Nutrition Group, Inc. Initiates Recall of Poultry Feed
Kent Nutrition Group, Inc. is recalling one lot of its Blue Seal Home Fresh Starter Amp Medicated Poultry Feed. The recall is being implemented due to the discovery of excess salt in the feed concerning lot number 1015072.
Sun Rich Fresh Foods Inc. Recalls Apple Slices Because Of Possible Health Risk
Sun Rich Fresh Foods Inc. of Richmond, BC, Canada is voluntarily recalling sliced apple and products containing sliced apples, from its Northeast Fresh Facility located in Brampton, ON, Canada because they have the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.
FDA approves Raplixa to help control bleeding during surgery
The U.S. Food and Drug Administration today approved Raplixa (fibrin sealant [human]), the first spray-dried fibrin sealant approved by the agency. It is used to help control bleeding during surgery.